Tenax Therapeutics Inc
Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatini… Read more
Tenax Therapeutics Inc (TENX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.095x
Based on the latest financial reports, Tenax Therapeutics Inc (TENX) has a cash flow conversion efficiency ratio of -0.095x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.15 Million) by net assets ($96.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tenax Therapeutics Inc - Cash Flow Conversion Efficiency Trend (1995–2024)
This chart illustrates how Tenax Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tenax Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tenax Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Townsquare Media Inc
NYSE:TSQ
|
-0.232x |
|
Kerevitas Gida Sanayi ve Ticaret AS
IS:KERVT
|
0.003x |
|
American Lithium Corp. Common Stock
NASDAQ:AMLI
|
-0.019x |
|
Mercer International Inc
NASDAQ:MERC
|
0.678x |
|
Bike24 Holding AG
F:BIKE
|
0.059x |
|
ITEK Inc
KQ:119830
|
0.034x |
|
Cullman Bancorp Inc.
NASDAQ:CULL
|
0.017x |
|
Boa Safra Sementes S.A
SA:SOJA3
|
-0.084x |
Annual Cash Flow Conversion Efficiency for Tenax Therapeutics Inc (1995–2024)
The table below shows the annual cash flow conversion efficiency of Tenax Therapeutics Inc from 1995 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $91.99 Million | $-14.81 Million | -0.161x | +77.92% |
| 2023-12-31 | $8.10 Million | $-5.90 Million | -0.729x | +90.94% |
| 2022-12-31 | $1.49 Million | $-12.01 Million | -8.048x | -214.65% |
| 2021-12-31 | $4.24 Million | $-10.86 Million | -2.558x | -27.58% |
| 2020-12-31 | $4.63 Million | $-9.27 Million | -2.005x | -0.09% |
| 2019-12-31 | $3.77 Million | $-7.56 Million | -2.003x | -328.73% |
| 2018-12-31 | $11.77 Million | $-5.50 Million | -0.467x | +65.82% |
| 2017-12-31 | $8.88 Million | $-12.14 Million | -1.367x | -47.62% |
| 2016-12-31 | $17.14 Million | $-15.87 Million | -0.926x | -473.89% |
| 2015-12-31 | $60.42 Million | $-9.75 Million | -0.161x | -44.39% |
| 2014-12-31 | $82.89 Million | $-9.26 Million | -0.112x | 0.00% |
| 2013-12-31 | $82.89 Million | $-9.26 Million | -0.112x | +31.20% |
| 2012-12-31 | $30.30 Million | $-4.92 Million | -0.162x | -101.68% |
| 2011-12-31 | $-871.46K | $-8.40 Million | 9.643x | +338.84% |
| 2010-12-31 | $2.13 Million | $-8.59 Million | -4.037x | -281.02% |
| 2009-12-31 | $3.83 Million | $-4.06 Million | -1.060x | -207.36% |
| 2008-12-31 | $6.60 Million | $-2.28 Million | -0.345x | -113.89% |
| 2007-12-31 | $-458.25K | $-1.14 Million | 2.483x | +121.52% |
| 2006-12-31 | $186.22K | $-2.15 Million | -11.537x | -449.29% |
| 2005-12-31 | $948.40K | $-1.99 Million | -2.100x | -71.48% |
| 2004-12-31 | $1.45 Million | $-1.77 Million | -1.225x | +32.60% |
| 2003-12-31 | $1.15 Million | $-2.09 Million | -1.817x | -18.33% |
| 2002-12-31 | $1.24 Million | $-1.90 Million | -1.536x | -239.02% |
| 2001-12-31 | $3.39 Million | $-1.54 Million | -0.453x | -190.35% |
| 2000-12-31 | $5.85 Million | $-913.30K | -0.156x | -101.95% |
| 1999-12-31 | $-100.00K | $-800.00K | 8.000x | +588.53% |
| 1998-12-31 | $351.55K | $-575.69K | -1.638x | -153.05% |
| 1997-12-31 | $-282.51K | $-872.15K | 3.087x | +20.56% |
| 1996-12-31 | $-597.60K | $-1.53 Million | 2.561x | 0.00% |
| 1995-12-31 | $-597.60K | $-1.53 Million | 2.561x | -- |